- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Large Cap High Growth Potential
Danish Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
2
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
GMAB | DKK 1,424.50 | -5.2% | -25.1% | DKK 90.5b | DKK 2,292.13 | PE19.2x | E21.4% | n/a | ||
NOVO B | DKK 607.30 | -2.4% | -22.3% | DKK 2.7t | DKK 824.65 | PE28.5x | E13.5% | 1.6% |
Page 1 of 1